Dental Support Device During Breastfeeding as a Mean for Pain Control

Sponsor
Tel-Aviv Sourasky Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT02639663
Collaborator
(none)
700
2
24

Study Details

Study Description

Brief Summary

Leboride is a dental support device that was developed for reducing pain during active labor. It is made of an inert material, placed in the woman's mouth and does not disturb breathing, talking, or any other activity expected during labor. It is a single-use device, each user receives a new one.

This study hypothesis is that the Leboride use can reduce pain during breastfeeding, by that improve women's breastfeeding experience, and increase breastfeeding rates.

Condition or Disease Intervention/Treatment Phase
  • Device: dental device
Phase 3

Detailed Description

Dental support device is effective in increasing isometric force in different muscle contraction [1-7]. In 2009 an avant-garde study [8] found in a small cohort that dental support device during labor, can shorten the second stage and reduce obstetrical interventions such as operative delivery and cesarean section. In this stage the woman has to contract muscles in order to push the fetus through the birth canal.

Leboride is a dental support device that was developed for reducing pain during active labor. It is made of an inert material, placed in the woman's mouth and does not disturb breathing, talking, or any other activity expected during labor. It is a single-use device, each user receives a new one.

This study hypothesis is that the Leboride use can reduce pain during breastfeeding, by that improve women's breastfeeding experience, and increase breastfeeding rates.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
700 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Dental Support Device During Breastfeeding as a Mean for Pain Control
Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Jan 1, 2017
Anticipated Study Completion Date :
Jan 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: women whom are interested in breastfeeding and have not begun.

Post-partum primi and multiparous women Post-partum primipara and multiparous women whom are interested in breastfeeding and have not begun yet. This arm will be randomized into 2 groups Intervention group: participants will receive the dental device and be instructed to use it during breastfeeding. Control group: participants will not receive any device for breastfeeding pain control

Device: dental device
Leboride Post-partum primi and multiparous women whom are interested in breastfeeding and have not begun yet. This arm will be randomized into 2 groups Intervention group: participants will receive the dental device and be instructed to use it during breastfeeding. Control group: participants will not receive any device for breastfeeding pain control Post-partum women that have already begun breast feeding, will receive the dental device and each woman will be serve as her own control (breastfeeding before and after the use of the dental device.

Experimental: Post-partum women that have already begun breast feeding

2. Post-partum women that have already begun breast feeding, will receive the dental device and each woman will be serve as her own control (breastfeeding before and after the use of the dental device.

Device: dental device
Leboride Post-partum primi and multiparous women whom are interested in breastfeeding and have not begun yet. This arm will be randomized into 2 groups Intervention group: participants will receive the dental device and be instructed to use it during breastfeeding. Control group: participants will not receive any device for breastfeeding pain control Post-partum women that have already begun breast feeding, will receive the dental device and each woman will be serve as her own control (breastfeeding before and after the use of the dental device.

Outcome Measures

Primary Outcome Measures

  1. Rate of change in of the vas scores before and after using this device [24 months]

Secondary Outcome Measures

  1. Duration of breastfeeding [24 months]

  2. The rate of cessation of breastfeeding because of pain [24 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Maternal age 18-45 years. Normal vital signs.

Exclusion Criteria:

Contraindications for breastfeeding. Significant systemic disease that cause pain or require chronic pain relief.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Tel-Aviv Sourasky Medical Center

Investigators

  • Principal Investigator: Ariel many, professor, Tel Aviv Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT02639663
Other Study ID Numbers:
  • 559-15-TLV
First Posted:
Dec 24, 2015
Last Update Posted:
Dec 24, 2015
Last Verified:
Dec 1, 2015
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No

Study Results

No Results Posted as of Dec 24, 2015